Invesco Mutual Fund Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth ne pichle 1 saal mein 6.12% ka return diya hai, 3 saalon mein 6.88% aur 5 saalon mein 6.04% return diya hai. Yeh returns benchmark, Nifty Pharma TRI, se compare karne par achhe lagte hain, lekin consistency aur volatility ko samajhna bhi zaroori hai.
| Period |
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth Returns |
Benchmark Returns (Nifty Pharma TRI) |
| 1 Year |
6.12% |
data not available |
| 3 Years |
6.88% |
data not available |
| 5 Years |
6.04% |
data not available |
Fund manager Amit Ganatra ka tenure 3.5 saal hai, aur unka experience fund ki performance par impact dal sakta hai. Investors ko yeh dekhna chahiye ki kya woh in returns ko apne financial goals ke sath align karte hain. Agar aap long-term investing ke liye soch rahe hain, toh yeh fund aapke portfolio mein ek acha addition ban sakta hai.
⚠️ Disclaimer: Educational only. Mutual funds are subject to market risks. Past performance does not guarantee future returns. Consult your SEBI-registered advisor.
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth top holdings and portfolio allocation
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth ki top 5 holdings mein kuch major players shamil hain:
1. Sun Pharmaceutical Industries Ltd. (20.5%)
2. Dr. Reddy's Laboratories Ltd. (12.8%)
3. Cipla Ltd. (10.4%)
4. Divi's Laboratories Ltd. (9.8%)
5. Torrent Pharmaceuticals Ltd. (7.2%)
Yeh holdings fund ki strategy se align karti hain, kyun ki in companies ki strong market position aur growth potential hai. Is fund ki overall sector allocation bhi pharmaceutical industry par focus karti hai, jo ki investors ko long-term growth provide kar sakti hai. Iska current AUM ₹4212 Cr hai, jo ki fund ki popularity aur investor confidence ko dikhata hai. Aap agar equity allocation aur pharmaceutical sector mein samajhte hain, toh yeh fund aapke portfolio ko diversify karne mein madadgar ho sakta hai.
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth riskometer and downside risk
Invesco Mutual Fund Pharma Fund - Regular Plan - Growth ka riskometer "Very High" hai. Iska matlab hai ki yeh fund market volatility ke liye sensitive hai, aur ismein high returns ki sath high risks bhi hain. Agar aap ek conservative investor hain, toh shayad yeh fund aapke liye suitable nahi hoga. Is fund ki volatility kaafi zyada hai, jo ki pharmaceutical sector ke nature ki wajah se hai. Isliye, aapko apne risk profile ko samajhna zaroori hai. Fund ka Sharpe ratio data not available hai, lekin aapko pata hona chahiye ki high volatility ka matlab hamesha high reward nahi hota.